MISSION“Koa Bio was founded to solve a simple but urgent problem: when a new drug-resistant bacterial threat emerges, there is no fast path from discovery to deployment. We bridge that gap by combining AI-driven biologics discovery with the operational infrastructure to scale and deliver validated candidates at speed. Based in Honolulu, Hawaii, we work alongside government agencies, defense research institutions, drug discovery partners, clinical networks, and global health organizations to protect those who protect us, and those who cannot protect themselves.”
—
LEADERSHIP BIO: Ben Boedeker
Ben Boedeker, MD, PhD, MBA
Director of Military MedicineDr. Boedeker is a retired Colonel in the U.S. Air Force Medical Corps with decades of service spanning novel analgesic development, far-forward battlefield airway management, and telemedicine integration for military healthcare. He earned his DVM from Colorado State University, his PhD in pathology from Georgetown University, and his MD from the University of Hawaii John A. Burns School of Medicine, with a residency in anesthesiology at Walter Reed Army Medical Center. Prior to joining Koa Bio, Dr. Boedeker served as Director of Military Medicine at Rion, a clinical-stage regenerative medicine company, and as Medical Director and Co-Founder of Lincoln Therapeutics, where he collaborated with the Department of Defense to develop non-narcotic pain management solutions for battlefield injuries.
PARTNERS & AFFILIATIONSUS Government & Defense
1
Koa Bio collaborates with U.S. government agencies and defense research institutions, including scientists at the Walter Reed Army Institute of Research (WRAIR), to identify and prioritize the most operationally critical pathogenic threats facing military personnel and civilian populations; as well as to scale and deploy development and path-to-man.
Next-Gen Drug Discovery Teams
2
Biologics candidates are generated using JURA Bio's Sovereign AI platform, which designs, builds, and tests billions of molecular candidates using manufacturing-aware generative models. Read more at https://www.jurabio.com
Clinical & Medical Networks
3
Koa Bio works with physicians, military medical professionals, and clinical partners to ensure that validated candidates are informed by real-world clinical need and ready for deployment in far-forward and austere care environments.
Global Health Organizations & NGOs
4
Koa Bio is positioned to partner with international health organizations, humanitarian NGOs, and allied-nation health security programs to extend the reach of novel biologic countermeasures beyond U.S. defense applications.